Carcinoid | Treatment (n) | Outcome (n) | Median FU (mo) | Range FU (mo) | Remarks |
---|---|---|---|---|---|
Typical (75) | IBT (38) | CR (33) | 120 | (73–241) | |
Residue (3) | 168 | (140–205) | 1 unfit, 2 refused | ||
Recurrence (2) | 10 and 63 | IBT—Recurrence | |||
98 and 29 | BT—July 2014 | ||||
Surgery (37) | CR (35) | 129 | (60–267) | ||
Recurrence (2) | 47 and 104 | IBT—Recurrence | |||
57 and 111 | Surgery—July 2014 | ||||
Atypical (25) | IBT (5) | CR (5) | 109 | (83–170) | |
Surgery (20) | CR (18) | 88.5 | (60–159) | ||
Recurrence (2) | 116 and 198 | IBT—Recurrence | |||
113 and 79 | Surgery—July 2014 |
No residual tumour detected macroscopically (videobronchoscopy, high resolution CT) and microscopically (biopsy and brush specimens).
CR, complete remission; BT, bronchoscopic treatment.